HS-10241

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HS-10241, covering 2016-11-30 to 2025-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function [Phase 1]

See pricing